These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11563871)

  • 1. Human papillomavirus as a form of risk assessment.
    Chew GK; Cruickshank ME
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):759-68. PubMed ID: 11563871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV testing in cervical screening.
    Cuzick J
    Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
    [No Abstract]   [Full Text] [Related]  

  • 3. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus in cervical cancer screening: important role as biomarker.
    Boulet GA; Horvath CA; Berghmans S; Bogers J
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):810-7. PubMed ID: 18398022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
    Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
    J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
    Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
    J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical neoplasia: are adjunctive tests to cervical cytology worthwhile?
    Greenberg MD; Sedlacek TV; Campion MJ
    Clin Obstet Gynecol; 1995 Sep; 38(3):600-9. PubMed ID: 8612370
    [No Abstract]   [Full Text] [Related]  

  • 11. Time to consider HPV testing in cervical screening.
    Cuzick J
    Ann Oncol; 2001 Nov; 12(11):1511-4. PubMed ID: 11822748
    [No Abstract]   [Full Text] [Related]  

  • 12. [HIV, HPV and cervical pathology].
    Quéreux C; Bory JP
    Contracept Fertil Sex; 1997 Feb; 25(2):120-4. PubMed ID: 9116771
    [No Abstract]   [Full Text] [Related]  

  • 13. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
    Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
    Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus DNA detection for cervical cancer screening.
    Press RD
    Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
    Millikan RC
    J Natl Cancer Inst; 1994 Mar; 86(5):392-3. PubMed ID: 8308931
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
    van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
    Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of cervical papillomavirus infections. Recent knowledge].
    Mougin C; Dalstein V; Prétet JL; Gay C; Schaal JP; Riethmuller D
    Presse Med; 2001 Jun; 30(20):1017-23. PubMed ID: 11433694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening based on papillomavirus detection: too many false alarms.
    Prescrire Int; 2010 Aug; 19(108):178-9. PubMed ID: 20939456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.